JOHN HOPE FRANKLIN CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 5K

Market Cap: -

Website: http://www.duke.edu

Clinical Trials

Esmolol for Treatment of Perioperative Tachycardia

Phase 3

Terminated

Conditions: High-risk, Non-cardiovascular Surgeries

Interventions: Drug: Esmolol

First Posted Date: 2010-09-24

Last Posted Date: 2014-12-12

Lead Sponsor: Duke University

Target Recruit Count: 76

Registration Number: NCT01208402

Locations: 🇺🇸
Durham VA Medical Center, Durham, North Carolina, United States
🇺🇸
Ohio State University, Columbus, Ohio, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer

Phase 2

Terminated

Conditions: Metastatic Breast Cancer

Interventions: Drug: Abraxane
Drug: Carboplatin

First Posted Date: 2010-09-22

Last Posted Date: 2014-12-15

Lead Sponsor: Duke University

Target Recruit Count: 10

Registration Number: NCT01207102

Locations: 🇨🇳
Peking University School of Oncology/Beijing Cancer Hospital, Beijing, China
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Optimizing Ovulation Induction in the Poor Responder

Not Applicable

Withdrawn

Conditions: IVF Poor Responders

Interventions: Drug: Estradiol
Drug: Oral Contraceptive Pills (OCP)

First Posted Date: 2010-09-13

Last Posted Date: 2012-11-21

Lead Sponsor: Duke University

Registration Number: NCT01200537

Locations: 🇺🇸
Duke Fertility Center, Durham, North Carolina, United States

Apremilast for Chronic Plaque Psoriasis (CPP) Patients Who Have Failed One Course of Biologic Therapy

Phase 2

Withdrawn

Conditions: Chronic Plaque Psoriasis

Interventions: Drug: apremilast

First Posted Date: 2010-09-13

Last Posted Date: 2014-07-15

Lead Sponsor: Duke University

Registration Number: NCT01200264

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Study of Bimatoprost Gel on Eyelash Growth

Phase 3

Completed

Conditions: Hypotrichosis
Madarosis

Interventions: Drug: Bimatoprost eyelash gel

First Posted Date: 2010-09-13

Last Posted Date: 2014-07-16

Lead Sponsor: Duke University

Target Recruit Count: 20

Registration Number: NCT01200251

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection

Phase 2

Completed

Conditions: Bacteremia

Interventions: Drug: Vancomycin

First Posted Date: 2010-08-31

Last Posted Date: 2018-01-05

Lead Sponsor: Duke University

Target Recruit Count: 509

Registration Number: NCT01191840

Locations: 🇺🇸
William Beaumont Hospital, Royal Oak, Michigan, United States
🇺🇸
David Geffen School of Medicine UCLA, Los Angeles, California, United States
🇺🇸
University of Colorado, Denver, Colorado, United States

and more 12 locations

Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery

Not Applicable

Withdrawn

Conditions: Neurocognitive Dysfunction

Interventions: Drug: atorvastatin

First Posted Date: 2010-08-23

Last Posted Date: 2015-10-14

Lead Sponsor: Duke University

Registration Number: NCT01186289

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

BraveNet Multi-Center Study on Integrative Medicine Treatment Approaches for Pain

Completed

Conditions: Chronic Pain

First Posted Date: 2010-08-23

Last Posted Date: 2023-10-26

Lead Sponsor: Duke University

Target Recruit Count: 418

Registration Number: NCT01186341

Locations: 🇺🇸
Scripps Center for Integrative Medicine, La Jolla, California, United States
🇺🇸
UCSF Osher Center for Integrative Medicine, San Francisco, California, United States
🇺🇸
Venice Family Clinic Simms/Mann Health and Wellness Center, Santa Monica, California, United States

and more 6 locations

Understanding of Genetic Risk Information for Type 2 Diabetes

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Behavioral: Receiving results via genetic counselor

First Posted Date: 2010-08-23

Last Posted Date: 2012-12-17

Lead Sponsor: Duke University

Target Recruit Count: 300

Registration Number: NCT01186354

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Reduced Radiation in Patients With Diffuse Large B-cell Lymphoma

Not Applicable

Completed

Conditions: Diffuse Large B-cell Lymphoma

Interventions: Radiation: Radiation Therapy

First Posted Date: 2010-08-23

Last Posted Date: 2020-06-02

Lead Sponsor: Duke University

Target Recruit Count: 63

Registration Number: NCT01186978

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
🇺🇸
Duke Raleigh Hospital, Raleigh, North Carolina, United States
🇺🇸
Durham Regional Hospital, Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy